ARCHIVES

Medicare to cut payments for cancer drugs by 2-8%. ASCO estimates total cut in reimbursement at $500 million.

This article is from The Cancer Letter archive.

Vol. 30 No. 31 | July 30, 2004

Download PDF Visit The Full Archive

Related Articles

DCBD Board Okays Recombinant DNA Diagnosis Concept, Two Others, But Rejects Three

June 3, 1983

DRCCA Board Fails To Agree on New Guidelines For Cancer Control Core Grants, Will Try Again

June 25, 1981

Bristol-Myers Awards 42.5 Million In Cancer Grants

October 21, 1977

CCOPs, Research Base Awards Are Listed

November 19, 1993

Black Women More Likely To Delay Diagnosis, Treatment

July 29, 2005

NCI Offers Mouse Strains, Tissue Microarrays, Online.

March 9, 2001